WeVote
Log In

Bill

Bill

HB 2329

Health insurance; prescription drug formularies.

2025 Regular Session Introduced by Mark Sickles

Virginia bill regulates health insurance prescription drug formularies to improve medication access and affordability by restricting insurer cost-control practices.

Left in Labor and Commerce
0
WeVote Research Nonpartisan
Bill Summary · HB 2329

Legislative bill overview

HB 2329 addresses how health insurance companies manage prescription drug formularies—the lists of covered medications and their cost-sharing requirements. The bill, sponsored by Mark Sickles in Virginia, seeks to regulate formulary practices, though the specific provisions are not detailed in the available legislative history.

Why is this important

Prescription drug formularies directly affect patients' medication access and out-of-pocket costs. Restrictive formularies can force patients onto less effective medications or burden them with high copays, making this a significant healthcare affordability issue that impacts treatment decisions and health outcomes.

Potential points of contention

  • Insurance industry burden: Insurers and pharmacy benefit managers may argue that formulary restrictions are necessary cost-control mechanisms, and regulatory mandates increase administrative costs and premiums
  • Coverage vs. cost trade-off: The bill may pit broader medication access against insurance affordability, creating tension between patient choice and premium sustainability
  • Implementation complexity: Defining appropriate formulary standards without being overly prescriptive requires careful balance, and enforcement mechanisms could be administratively challenging

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.